Skip to content

Clinical trials

Phase 2 Osteoporosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 2 Country / region: United States Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20033
20043
20054
20062
20073
20085
20092
20103
20114
20123
20133
20142
20153
20171
20183
20191
20202
20211
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Terminated8
Unknown status4
Withdrawn1
Recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital7
National Center for Complementary and Integrative Health (NCCIH)4
Northwestern University4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Creighton University2
Duke University2
Elizabeth Shane2
Helen Hayes Hospital2
Medical University of South Carolina2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis72
Bone Diseases, Metabolic19
Spinal Cord Injuries8
Osteoporosis, Postmenopausal6
Bone Diseases5
Fractures, Bone5
Musculoskeletal Diseases4
Spinal Cord Diseases4
Anorexia Nervosa3
Bone Resorption3

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.